A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease (Q34432112)

2 August 2017

A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

2 August 2017

1 reference

Noriaki Takabatake

1

1 reference

2 August 2017

Makoto Sata

2

1 reference

2 August 2017

Sumito Inoue

3

1 reference

2 August 2017

Yoko Shibata

4

1 reference

2 August 2017

Shuichi Abe

5

1 reference

2 August 2017

Toshihiro Wada

6

1 reference

2 August 2017

Jun-Ichi Machiya

7

1 reference

2 August 2017

Guijin Ji

8

1 reference

2 August 2017

Tadashi Matsuura

9

1 reference

2 August 2017

Yasuchika Takeishi

10

1 reference

2 August 2017

Masaaki Muramatsu

11

1 reference

2 August 2017

Isao Kubota

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

7 July 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

1 reference

2 August 2017

172

1 reference

2 August 2017

9

1 reference

2 August 2017

1097-1104

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

2 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Systemic effects in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Secretory phospholipases A2 as multivalent mediators of inflammatory and allergic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Cloning and characterization of novel mouse and human secretory phospholipase A(2)s

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Allergic rhinitis, asthma, airway biology, and chronic obstructive pulmonary disease in AJRCCM in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-319OC

10.1164/RCCM.200503-319OC

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference